|Innovation Title||Categories||Lead Inventor|
HPTP Phosphatase in Cancer
|Kinch, Michael S|
Dr. Michael S. Kinch is the Associate Vice Chancellor and Director, Center for Research Innovation at Washington University at St. Louis. Before joining Washington University, Dr. Kinch served as Business Managing Director of the Center for Molecular Discovery at Yale University; Chief Scientific Officer and Vice President of Research and Development at Functional Genetics, Inc.; he founded and served as head of the Departments of Cancer Biology and In Vivo Biology at MedImmune, Inc.; and was a tenured Associate Professor of Cellular Pharmacology at Purdue University. He is a cofounder of the Institute for Life Sciences Collaboration and on the Board of Directors for the Therapeutic Research Foundation. He has chaired more than a dozen study sections for Department of Defense Congressionally-Directed Medical Research Programs for breast and prostate cancers. Dr. Kinch received a B.S. in Molecular Genetics from The Ohio State University, a Ph.D. in Microbiology and Immunology from Duke University, and was a postdoctoral fellow at the University of North Carolina at Chapel Hill. Dr. Kinch's scientific expertise includes preclinical drug development for cancer, immunological and infectious diseases with small molecules, monoclonal antibodies, and other biologics.
For additional information, visit Dr. Kinch's Washington University webpage: http://crib.wustl.edu/archives/author/kinchm